SEER Stat Fact Sheets: Testis Cancer

Lifetime risk estimates are not available with the current statistics release, but will be added later when population data for older age groups are available.

Statistics at a GlanceShow More

At a Glance

  • Estimated New Cases in 2016 8,720
  • % of All New Cancer Cases0.5%
  • Estimated Deaths in 2016 380
  • % of All
    Cancer Deaths

Percent Surviving
5 Years

95.4% 2006-2012

Number of New Cases and Deaths per 100,000: The number of new cases of testis cancer was 5.7 per 100,000 men per year. The number of deaths was 0.3 per 100,000 men per year. These rates are age-adjusted and based on 2009-2013 cases and deaths.

Lifetime Risk of Developing Cancer: Approximately 0.4 percent of men will be diagnosed with testis cancer at some point during their lifetime, based on 2010-2012 data.

Prevalence of This Cancer: In 2013, there were an estimated 240,372 men living with testis cancer in the United States.

Survival StatisticsShow More

How Many People Survive 5 Years Or More after Being Diagnosed with Testis Cancer?

Relative survival statistics compare the survival of patients diagnosed with cancer with the survival of people in the general population who are the same age, race, and sex and who have not been diagnosed with cancer. Because survival statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. No two patients are entirely alike, and treatment and responses to treatment can vary greatly.


Percent Surviving
5 Years


Based on data from SEER 18 2006-2012. Gray figures represent those who have died from testis cancer. Green figures represent those who have survived 5 years or more.

Additional Information

Cancer stage at diagnosis, which refers to extent of a cancer in the body, determines treatment options and has a strong influence on the length of survival. In general, if the cancer is found only in the part of the body where it started it is localized (sometimes referred to as stage 1). If it has spread to a different part of the body, the stage is regional or distant. The earlier testis cancer is caught, the better chance a person has of surviving five years after being diagnosed. For testis cancer, 67.8% are diagnosed at the local stage. The 5-year survival for localized testis cancer is 99.3%.

Percent of Cases & 5-Year Relative Survival by Stage at Diagnosis: Testis Cancer
Percent of Cases by Stage
  • Localized (68%)
    Confined to Primary Site
  • Regional (19%)
    Spread to Regional Lymph Nodes
  • Distant (12%)
    Cancer Has Metastasized
  • Unknown (1%)
68% localized; 19% regional; 12% distant; 1% unknown
5-Year Relative Survival
99.3% localized; 96.1% regional; 73.9% distant; 77.4% unstaged

SEER 18 2006-2012, All Races, Males by SEER Summary Stage 2000

Additional Information

Number of New Cases and DeathsShow More

How Common Is This Cancer?

Compared to other cancers, testis cancer is rare.

Common Types of Cancer Estimated New
Cases 2016
Deaths 2016
1. Breast Cancer (Female) 246,660 40,450
2. Lung and Bronchus Cancer 224,390 158,080
3. Prostate Cancer 180,890 26,120
4. Colon and Rectum Cancer 134,490 49,190
5. Bladder Cancer 76,960 16,390
6. Melanoma of the Skin 76,380 10,130
7. Non-Hodgkin Lymphoma 72,580 20,150
8. Thyroid Cancer 64,300 1,980
9. Kidney and Renal Pelvis Cancer 62,700 14,240
10. Leukemia 60,140 24,400
- - -
24. Testis Cancer 8,720 380

Testis cancer represents 0.5% of all new cancer cases in the U.S.


In 2016, it is estimated that there will be 8,720 new cases of testis cancer and an estimated 380 people will die of this disease.

Testicular cancer is most common in young adults. The number of new cases of testis cancer was 5.7 per 100,000 men per year based on 2009-2013 cases.

Percent of New Cases by Age Group: Testis Cancer
6.2% under 20; 50.0% 20-34; 22.9% 35-44; 13.2% 45-54; 5.5% 55-64; 1.4% 65-74; 0.6% 75-84; 0.2% 85 and older

Testis cancer is most frequently diagnosed among men aged 20-34.

Median Age
At Diagnosis


SEER 18 2009-2013, All Races, Males

Number of New Cases per 100,000 Persons by Race/Ethnicity: Testis Cancer
  • Male 5.7All RacesSex-Specific Cancer
  • Male 6.7White
  • Male 1.5Black
  • Male 2.1Asian /
    Pacific Islander
  • Male 4.9American Indian /
    Alaska Native
  • Male 5.0Hispanic
  • Male 5.8Non-Hispanic

SEER 18 2009-2013, Age-Adjusted

The number of deaths was 0.3 per 100,000 men per year based on 2009-2013.

Percent of Deaths by Age Group: Testis Cancer
1.8% under 20; 34.7% 20-34; 18.3% 35-44; 20.6% 45-54; 11.3% 55-64; 5.5% 65-74; 4.8% 75-84; 3.0% 85 and older

The percent of testis cancer deaths is highest among men aged 20-34.

Median Age
At Death


U.S. 2009-2013, All Races, Males

Number of Deaths per 100,000 Persons by Race/Ethnicity: Testis Cancer
  • Male 0.3All RacesSex-Specific Cancer
  • Male 0.3White
  • Male 0.1Black
  • Male 0.1Asian /
    Pacific Islander
  • Male 0.3American Indian /
    Alaska Native
  • Male 0.3Hispanic
  • Male 0.2Non-Hispanic

U.S. 2009-2013, Age-Adjusted

Trends in RatesShow More

Changes Over Time

Keeping track of the number of new cases, deaths, and survival over time (trends) can help scientists understand whether progress is being made and where additional research is needed to address challenges, such as improving screening or finding better treatments.

Using statistical models for analysis, rates for new testis cancer cases have been rising on average 0.8% each year over the last 10 years. Death rates have been stable over 2004-2013. 5-year survival trends are shown below the figure.

More About This CancerShow More

Cancer and the Testis

Anatomy of the male reproductive and urinary systems; drawing shows front and side views of ureters, lymph nodes, rectum, bladder, prostate gland, vas deferens, urethra, penis, testicles, seminal vesicle, and ejaculatory duct.
Figure: Anatomy of the Male Reproductive and Urinary Systems
Click to enlarge.

Testicularcancer forms in tissues of one or both testicles. Most testicular cancers begin in germ cells (cells that make sperm) and are called testicular germ cell tumors.

Additional Information

More Information

Here are some resources for learning more about testicular cancer.


All statistics in this report are based on statistics from SEER and the Centers for Disease Control and Prevention's National Center for Health Statistics. Most can be found within:

Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2013, National Cancer Institute. Bethesda, MD,, based on November 2015 SEER data submission, posted to the SEER web site, April 2016.

Suggested Citation

All material in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated.

SEER Cancer Statistics Factsheets: Testis Cancer. National Cancer Institute. Bethesda, MD,

This factsheet focuses on population statistics that are based on the US population. Because these statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. To see tailored statistics, browse the SEER Cancer Statistics Review. To see statistics for a specific state, go to the State Cancer Profiles.

The statistics presented in this factsheet are based on the most recent data available, most of which can be found in the SEER Cancer Statistics Review. In some cases, different year spans may be used. Estimates for the current year are based on past data.

Cancer is a complex topic. There is a wide range of information available. This factsheet does not address causes, symptoms, diagnosis, treatment, follow-up care, or decision making, although it provides links to information in many of these areas.